Finally, additional screening for breast cancer and risk-reducing interventions through chemoprevention and surgical procedures can be undertaken by the individual and family members who are known BRCA1 or BRCA2 germline mutation carriers to prevent future cancers. This evidence concerns the gene BRCA2 and breast cancer.